Last Close
319.55 $
Jul 2, 26
Market Cap
6.4 B $
Q1 2026 (TTM)
52-Week Range
%+181.1
%37.7
1.88
1.99
%0.0
-%14.1
1M
+37.3%
3M
+60.1%
6M
+69.0%
YTD
+69.0%
1Y
+181.1%
3Y
+339.7%
Returns are computed from split-adjusted closes; dividends are not included.
Stock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
LGND last closed at 319.55 $ (Jul 2, 26). Price data is refreshed after every trading day.
Ligand Pharmaceuticals Incorporated trades at a trailing-twelve-month P/E of 41.38. See the comparison tables on the Peers tab for the industry context.
Ligand Pharmaceuticals Incorporated (LGND) has a market capitalization of approximately 6.4 B $ as of the latest reported period.
Key peers of Ligand Pharmaceuticals Incorporated include TELIX Pharmaceuticals Ltd, CSL Ltd, Mesoblast Ltd. A detailed metric comparison is available on the Peers tab.
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.